Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study

Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study

Abstract Background Immune checkpoint inhibitors of programmed cell death protein 1 (PD-1) represent a significant breakthrough in treating head and neck squamous cell carcinoma (HNSCC), with long-lasting responses and prolonged survival observed in first- and second-line therapy. However, this is o...

Full description

Bibliographic Details
Main Authors:	Carinato Hélène, Ombline Conrad, Carole Pflumio, Christian Borel, Manon Voegelin, Alexandre Bernard, Philippe Schultz, Mihaela-Alina Onea, Alain Jung, Sophie Martin, Mickaël Burgy
Format:	Article
Language:	English
Published:	BMC 2023-12-01
Series:	BMC Cancer
Subjects:	Head and neck squamous cell carcinoma Spatial transcriptomic Immune response HNSCC tumour microenvironment Response biomarker
Online Access:	https://doi.org/10.1186/s12885-023-11672-x

Similar Items

A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCC
by: Changqian Wang, et al.
Published: (2024-03-01)

Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs
by: Hongxia Deng, et al.
Published: (2023-11-01)

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
by: Markus Hecht, et al.
Published: (2020-09-01)

The Landscape of Transmembrane Protein Family Members in Head and Neck Cancers: Their Biological Role and Diagnostic Utility
by: Oliwia Koteluk, et al.
Published: (2021-09-01)

Role and clinical significance of immunogenic cell death biomarkers in chemoresistance and immunoregulation of head and neck squamous cell carcinoma
by: Xuanyu Zhang, et al.
Published: (2023-11-01)

The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response
by: Gujie Wu, et al.
Published: (2022-04-01)

Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer <it>via</it> suppression of apoptosis
by: Cameron Sarina, et al.
Published: (2012-09-01)

PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas
by: Magda Kopczyńska, et al.
Published: (2020-09-01)

mRNA Subtype of Cancer-Associated Fibroblasts Significantly Affects Key Characteristics of Head and Neck Cancer Cells
by: Barbora Peltanová, et al.
Published: (2022-05-01)

DRH1 – a novel blood-based HPV tumour marker
by: Thomas Weiland, et al.
Published: (2020-06-01)

Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response
by: Sean P. Korpela, et al.
Published: (2021-01-01)

Cetuximab reconstitutes proinflammatory cytokine secretions and tumour-infiltrating capabilities of sMICA-inhibited NK cells in HNSCC tumour spheroids.
by: Stephan eKloess, et al.
Published: (2015-11-01)

Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
by: Karl Payne, et al.
Published: (2020-11-01)

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
by: Nicole Wiedenmann, et al.
Published: (2018-08-01)

Hormetic and synergistic effects of cancer treatments revealed by modelling combinations of radio - or chemotherapy with immunotherapy
by: Sanyi Tang, et al.
Published: (2023-10-01)

Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses
by: Yu-Pei Chen, et al.
Published: (2021-01-01)

Tumour microenvironment influences response to treatment in oesophageal adenocarcinoma
by: Clemence J. Belle, et al.
Published: (2023-12-01)

Mining TCGA database for prognostic genes in head and neck squamous cell carcinoma microenvironment
by: Qiu-Chi Ran, et al.
Published: (2021-03-01)

Senescence Induction by Combined Ionizing Radiation and DNA Damage Response Inhibitors in Head and Neck Squamous Cell Carcinoma Cells
by: Clara Dobler, et al.
Published: (2020-09-01)

Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer
by: Natalia Ricco, et al.
Published: (2019-09-01)

Unexpected Response to Nivolumab in a “Fast Progressor” Head and Neck Cancer Patient
by: Martina Napolitano, et al.
Published: (2019-09-01)

Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC
by: Xiangjin Gong, et al.
Published: (2023-10-01)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
by: Zhaomeng Guo, et al.
Published: (2023-08-01)

A novel immune signature predicts immunotherapy responsiveness and reveals the landscape of the tumor immune microenvironment in head and neck squamous cell carcinoma
by: Qiwei Wang, et al.
Published: (2022-11-01)

Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
by: Christian Borel, et al.
Published: (2020-09-01)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
by: Xin Wang, et al.
Published: (2019-02-01)

The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank
by: James M. Lonie, et al.
Published: (2023-10-01)

Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group – ESOI Joint Paper
by: Laure Fournier, et al.
Published: (2022-01-01)

Serum-derived exosomes promote CD8+ T cells to overexpress PD-1, affecting the prognosis of hypopharyngeal carcinoma
by: Qian Gao, et al.
Published: (2021-10-01)

MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma
by: Shine-Gwo Shiah, et al.
Published: (2021-11-01)

Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer
by: Stephanie Dorta-Estremera, et al.
Published: (2019-09-01)

NOTCH1 Intracellular Domain and the Tumor Microenvironment as Prognostic Markers in HNSCC
by: Benedikt Schmidl, et al.
Published: (2022-02-01)

Fundamental Principles of Raising an Antitumour Immune Response in Vivo: A Complex Model, a Case Report, and a Perspective
by: Suzy M. Scholl
Published: (2014-11-01)

Tumour‐microenvironment‐responsive Na2S2O8 nanocrystals encapsulated in hollow organosilica–metal–phenolic networks for cycling persistent tumour‐dynamic therapy
by: Yang Li, et al.
Published: (2024-04-01)

Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target
by: Jiaxin Li, et al.
Published: (2023-02-01)

Microwave Ablation of Liver, Kidney and Lung Lesions: One-Month Response and Manufacturer’s Charts’ Reliability in Clinical Practice
by: Julien Frandon, et al.
Published: (2022-05-01)

Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches
by: Shuang Wu, et al.
Published: (2020-11-01)

Inflammation and immunity in ovarian cancer
by: Diego Salas-Benito, et al.
Published: (2020-08-01)

The Intratumor Bacterial and Fungal Microbiome Is Characterized by HPV, Smoking, and Alcohol Consumption in Head and Neck Squamous Cell Carcinoma
by: Jaideep Chakladar, et al.
Published: (2022-10-01)

Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
by: Bijan Khademi, et al.
Published: (2013-06-01)